TrialBlood neoplasia2026

Longitudinal patient-reported outcomes and quality-of-life trajectories over 2 years in CAR-T therapy recipients.

Vincenzo J Pizzuti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.